According to the latest report by IMARC Group, titled “Fertility Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027, the global fertility services market size reached US$ 29.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 73.1 Billion by 2027, exhibiting a growth rate (CAGR) of 16% during 2022-2027. Fertility services refer to the services provided to support the treatment of infertility. These include in vitro fertilization (IVF), artificial insemination, surrogacy, Assisted Reproductive Technology (ART) procedures, and others, which help in resolving infertility issues among couples. In males, infertility is identified by low sperm count or decreased motility of sperm. On the other hand, for females, infertility may occur due to hormonal imbalances and the development of polyps and fibroids in the uterus.
Request to get the sample report: https://www.imarcgroup.com/fertility-services-market/requestsample
Global Fertility Services Market Trends:
The global market is primarily driven by the growing awareness regarding the success rates of infertility treatment. Apart from this, the rising number of fertility clinics worldwide is also propelling the market growth. Moreover, the easy accessibility and availability of healthcare facilities and the increasing healthcare and research expenditure are providing a boost to the market growth. Additionally, the widespread integration of fertility services with advanced techniques is further providing an impetus to market growth.
Global Fertility Services Market 2022-2027 Analysis and Segmentation:
Competitive Landscape with Key players:
- Instituto Bernabe
- INVO Bioscience
- Monash IVF Group
- Apollo Hospitals Enterprise
- Care Fertility Group
- Carolinas Fertility Institute
- Genea Limited
- The Cooper Companies
- Virtus Health
- Vitrolife
- The Johns Hopkins Health System
- Medicover Group
- Ovascience
- Progyny
- Xytex Cryo International
Breakup by Cause of Infertility:
- Male Infertility
- Female Infertility
Breakup by Procedure:
- In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
Surrogacy - In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI)
Intrauterine Insemination (IUI)
Others
Breakup by Service:
- Fresh Non-Donor
- Frozen Non-Donor
- Egg and Embryo Banking
- Fresh Donor
- Frozen Donor
Breakup by End-User:
- Fertility Clinics
- Hospitals
- Surgical Centres
- Clinical Research Institutes
- Cryobanks
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Comments
Post a Comment